A new class of drugs shows benefit for both cardiovascular and kidney conditions, but scientists should be cautious in designing trials that include both cardiovascular and kidney outcomes in the same analysis, according to a Northwestern Medicine review article.
Northwestern Medicine investigators have identified a potential combined targeted therapy approach for treating glioblastoma, according to a recent study published in the journal Scientific Reports.
For the first time, Northwestern Medicine scientists have uncovered the complex logic that determines how cochlear cells are connected to the brain during neurodevelopment, according to a recent study.
Feinberg investigators continue to investigate new treatments for COVID-19 and share insights on combating misinformation and mitigating the disease’s spread.
A drug that demonstrated neuroprotective effect and slowed disease progression in animal models of Parkinson’s disease showed no symptomatic benefit in patients with the neurodegenerative disorder, according to results from a clinical trial led by Northwestern Medicine investigators.
Abbey Filicko, a third-year medical student, presented findings from her community-based participatory research project in partnership with Chicago Public Schools at this year’s American Public Health Association (APHA) virtual annual meeting.
An experimental drug called ezogabine reduced spinal neuron excitability in patients with ALS, according to a recent study.
Homer1, a protein that’s important for neural plasticity and learning, is part of a large network of proteins in the brain that help ensure new connections are wired correctly, according to a new study.
A multi-disciplinary team of investigators led by Northwestern scientists have developed a novel wireless device that can constantly monitor pressure and temperature between the patient’s skin and prosthesis, improving overall comfort and wellbeing.
Vitrectomy surgery and intravitreal injections showed similar effectiveness in improving overall vision for patients with advanced diabetic retinopathy, according to results from a clinical trial published in JAMA.